Clinical Trial

Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to compare the effects of conventional Ultra High Temperature (UHT) milk containing both A1 and A2 type β-caseins (CON) with a2 UHT Milk containing A2 type β-casein only (A1PF) on inflammation, tolerance, and GI symptoms in pregnant women as well as infants' birth outcomes from 12 weeks' gestation up to 40 days post-birth.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-08
Trial Details
NCT Number NCT06980376
Lead Sponsor a2 Milk Company Ltd.
Collaborators: Edanz Inc, Cyanth (Wuxi) Health Technology Co. Ltd., Affiliated Hospital of Jiangnan University, Guangzhou Trials Medical
Conditions Healthy Pregnant Women
Enrollment 100 participants
Start Date 2025-08-25
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-07